Review: taking Zofran and Meclizine hydrochloride together


Summary

Drug interactions are reported among people who take Zofran and Meclizine hydrochloride together. This review analyzes the effectiveness and drug interactions between Zofran and Meclizine hydrochloride. It is created by eHealthMe based on reports of 464 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Zofran and Meclizine hydrochloride >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zofran

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. (latest outcomes from Zofran 25,842 users)

Meclizine Hydrochloride

Meclizine hydrochloride has active ingredients of meclizine hydrochloride. It is often used in dizziness. (latest outcomes from Meclizine hydrochloride 515 users)

On Aug, 24, 2016

464 people who take Zofran, Meclizine Hydrochloride are studied.


Number of reports submitted per year:

Zofran and Meclizine hydrochloride drug interactions.

Drug effectiveness over time:

Zofran:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 66.0% - (2 of 3 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Meclizine Hydrochloride:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zofran:
  • female: 41.0% - (5 of 12 people)
  • male: 100.0% - (1 of 1 people)
Meclizine Hydrochloride:
  • female: 8.0% - (1 of 12 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Zofran:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (2 of 2 people)
  • 40-49: 50.0% - (3 of 6 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 1 people)
Meclizine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 16.0% - (1 of 6 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • confusion
  • vertigo
  • dizziness
  • headache
  • insomnia
  • memory impairment
  • oedema
  • rash pruritic
  • anxiety
  • arthropathy
1 - 6 months:
  • candidiasis
  • hair loss
  • livedo reticularis
  • vertigo
  • adams-stokes syndrome
  • atrioventricular block
  • fall
  • acne
  • alopecia areata
  • angular cheilitis
1 - 2 years:
  • systolic bruit
2 - 5 years:
  • weight increased
5 - 10 years:
  • muscle pain
  • weight gain - unintentional
  • weight increased
10+ years:
  • muscle pain
  • weight gain - unintentional
not specified:
  • anxiety
  • pain
  • dizziness
  • asthenia
  • nausea
  • dyspnoea
  • arthralgia
  • back pain
  • hypertension
  • pneumonia

Most common drug interactions by gender *:

female:
  • anxiety
  • dizziness
  • fall
  • pain
  • weight decreased
  • nausea
  • vertigo
  • hypertension
  • diarrhoea
  • asthenia
male:
  • pain
  • anxiety
  • arthralgia
  • dyspnoea
  • osteonecrosis of jaw
  • pneumonia
  • dizziness
  • back pain
  • neuropathy peripheral
  • headache

Most common drug interactions by age *:

0-1:
  • decreased appetite
  • swelling
  • weight decreased
2-9:
  • diplopia
  • disease recurrence
  • strabismus
10-19:
  • pain
  • cerebrovascular accident
  • hypercoagulation
  • ischaemic stroke
  • pulmonary embolism
  • thrombosis
  • convulsion
  • dehydration
  • vomiting
  • abdominal pain
20-29:
  • anxiety
  • dizziness
  • vertigo
  • headache
  • cerebral thrombosis
  • cerebral venous thrombosis
  • cognitive disorder
  • fear
  • haemorrhagic transformation stroke
  • injury
30-39:
  • depression
  • abdominal pain
  • deep vein thrombosis
  • portal vein thrombosis
  • injury
  • ischaemia
  • mesenteric vein thrombosis
  • pancreatitis acute
  • thrombosis
  • chest pain
40-49:
  • nausea
  • pain
  • dizziness
  • insomnia
  • anxiety
  • diarrhoea
  • headache
  • left ventricular dysfunction
  • rash
  • asthenia
50-59:
  • pain
  • anxiety
  • vertigo
  • deep vein thrombosis
  • pneumonia
  • cardiac failure congestive
  • migraine
  • arthralgia
  • depression
  • asthenia
60+:
  • anxiety
  • dizziness
  • pain
  • asthenia
  • fall
  • dyspnoea
  • atrial fibrillation
  • back pain
  • anaemia
  • osteonecrosis of jaw

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zofran and Meclizine hydrochloride?

Can you answer these questions?

More questions for: Zofran, Meclizine hydrochloride

You may be interested in these reviews

More reviews for: Zofran, Meclizine hydrochloride

On eHealthMe, Zofran (ondansetron hydrochloride) is often used to treat nausea. Meclizine hydrochloride (meclizine hydrochloride) is often used to treat dizziness. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.